Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FHTX is expected to report earnings to fall 13.79% to -25 cents per share on August 11

Foghorn Therapeutics FHTX Stock Earnings Reports

Q2'26

Est.

$-0.25

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.08

Q2'25

Beat

by $0.07

The last earnings report on May 07 showed earnings per share of -28 cents, missing the estimate of -28 cents. With 118.96K shares outstanding, the current market capitalization sits at 219.00M.

View a ticker or compare two or three

Compare

FHTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for FHTX